Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Chemours Co Director's Dealing 2022

Apr 29, 2022

31561_dirs_2022-04-29_d4f59814-372b-40bc-bf48-eafc3ebfe6c6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Chemours Co (CC)
CIK: 0001627223
Period of Report: 2022-04-27

Reporting Person: Kane Erin N (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-04-27 Common Stock A 4442 Acquired 31785.5076 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Units $ Common Stock (4080.9852) 4080.9852 Direct

Footnotes

F1: Includes stock units and dividend equivalent units.

F2: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock.

F3: Payable upon separation from service.